Sun Pharma Advanced Research Company Limited · NSE: SPARC · BSE: 532872
Sun Pharma Advanced Research Company
Quarterly results as filed with BSE. Latest: Q1 FY27 (Apr–Jun 2026), filed 10 Aug 2026.
Q1 FY27 · Consolidated
Revenue
39.92₹ Cr
+314.1% vs year ago
Net profit
(20.78)₹ Cr
Loss narrowed vs year ago
EPS, basic
(0.64)₹
Loss narrowed vs year ago
Net margin
-52.1%
+486.0 pts vs year ago
Quarter by quarter
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 39.92 | +314.1% | (20.78) | Loss narrowed | (0.64) | 10 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 1,853.22 | 68x | 1,761.34 | Turned profit | 54.27 | 18 May 2026 |
| Q3 FY26Oct–Dec 2025 | 8.45 | −43.3% | (80.42) | Loss widened | (2.48) | 09 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 7.86 | −38.9% | (75.85) | Loss narrowed | (2.34) | 10 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 9.64 | −42.7% | (51.87) | Loss narrowed | (1.60) | 04 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 27.19 | +64.2% | (59.77) | Loss narrowed | (1.84) | 19 May 2025 |
| Q3 FY25Oct–Dec 2024 | 14.91 | +7.6% | (79.51) | Loss narrowed | (2.45) | 10 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 12.86 | −39.3% | (107.33) | Loss widened | (3.31) | 04 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 16.81 | — | (95.90) | — | (2.96) | 06 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 16.56 | — | (105.79) | — | (3.26) | 25 May 2024 |
| Q3 FY24Oct–Dec 2023 | 13.86 | — | (99.65) | — | (3.07) | 19 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 21.18 | — | (86.42) | — | (2.66) | 07 Nov 2023 |
Standalone results
| Quarter | Revenue | YoY | Net profit | YoY | EPS (₹) | Filed |
|---|---|---|---|---|---|---|
| Q1 FY27Apr–Jun 2026 | 39.92 | +314.1% | (20.98) | Loss narrowed | (0.65) | 10 Aug 2026 |
| Q4 FY26Jan–Mar 2026 | 1,853.22 | 68x | 1,760.70 | Turned profit | 54.26 | 18 May 2026 |
| Q3 FY26Oct–Dec 2025 | 8.45 | −43.3% | (80.57) | Loss widened | (2.48) | 09 Feb 2026 |
| Q2 FY26Jul–Sep 2025 | 7.86 | −38.9% | (75.97) | Loss narrowed | (2.34) | 10 Nov 2025 |
| Q1 FY26Apr–Jun 2025 | 9.64 | −42.7% | (52.03) | Loss narrowed | (1.60) | 04 Aug 2025 |
| Q4 FY25Jan–Mar 2025 | 27.19 | +64.2% | (60.98) | Loss narrowed | (1.88) | 19 May 2025 |
| Q3 FY25Oct–Dec 2024 | 14.91 | +7.6% | (79.71) | Loss narrowed | (2.46) | 10 Feb 2025 |
| Q2 FY25Jul–Sep 2024 | 12.86 | −39.3% | (107.69) | Loss widened | (3.32) | 04 Nov 2024 |
| Q1 FY25Apr–Jun 2024 | 16.81 | −29.8% | (96.84) | Loss widened | (2.98) | 06 Aug 2024 |
| Q4 FY24Jan–Mar 2024 | 16.56 | −65.3% | (106.69) | Loss widened | (3.29) | 25 May 2024 |
| Q3 FY24Oct–Dec 2023 | 13.86 | −89.4% | (99.65) | Turned loss | (3.07) | 19 Feb 2024 |
| Q2 FY24Jul–Sep 2023 | 21.18 | −32.8% | (86.42) | Loss widened | (2.66) | 07 Nov 2023 |
| Q1 FY24Apr–Jun 2023 | 23.95 | −15.8% | (95.35) | Loss widened | (2.94) | 07 Aug 2023 |
| Q4 FY23Jan–Mar 2023 | 47.69 | +88.9% | (81.99) | Loss widened | (2.55) | 22 May 2023 |
| Q3 FY23Oct–Dec 2022 | 131.09 | +110.9% | 10.15 | Turned profit | 0.37 | 13 Feb 2023 |
| Q2 FY23Jul–Sep 2022 | 31.54 | +13.2% | (68.40) | Loss widened | (2.52) | 09 Nov 2022 |
| Q1 FY23Apr–Jun 2022 | 28.46 | +29.4% | (82.35) | Loss widened | (3.03) | 09 Aug 2022 |
| Q4 FY22Jan–Mar 2022 | 25.24 | −10.0% | (71.05) | Loss widened | (2.69) | 18 May 2022 |
| Q3 FY22Oct–Dec 2021 | 62.15 | +185.0% | (15.84) | Loss narrowed | (0.60) | 05 Feb 2022 |
| Q2 FY22Jul–Sep 2021 | 27.87 | +58.0% | (55.14) | Loss narrowed | (2.09) | 02 Nov 2021 |
| Q1 FY22Apr–Jun 2021 | 21.99 | −88.1% | (61.37) | Turned loss | (2.34) | 27 Jul 2021 |
| Q4 FY21Jan–Mar 2021 | 28.06 | +23.6% | (56.72) | Loss narrowed | (2.16) | 18 May 2021 |
| Q3 FY21Oct–Dec 2020 | 21.81 | +11.3% | (67.62) | Loss widened | (2.58) | 09 Feb 2021 |
| Q2 FY21Jul–Sep 2020 | 17.64 | +2.6% | (83.49) | Loss widened | (3.19) | 10 Nov 2020 |
| Q1 FY21Apr–Jun 2020 | 185.45 | +970.7% | 56.69 | Turned profit | 2.16 | 05 Aug 2020 |
| Q4 FY20Jan–Mar 2020 | 22.71 | −73.2% | (99.54) | Loss widened | (3.80) | 03 Jun 2020 |
| Q3 FY20Oct–Dec 2019 | 19.60 | −1.4% | (55.51) | Loss narrowed | (2.12) | 01 Feb 2020 |
| Q2 FY20Jul–Sep 2019 | 17.19 | −72.0% | (63.16) | Loss widened | (2.41) | 05 Nov 2019 |
| Q1 FY20Apr–Jun 2019 | 17.32 | +3.0% | (94.19) | Loss widened | (3.59) | 30 Jul 2019 |
| Q4 FY19Jan–Mar 2019 | 84.83 | — | (9.35) | — | (0.37) | 08 May 2019 |
| Q3 FY19Oct–Dec 2018 | 19.88 | — | (69.02) | — | (2.72) | 05 Feb 2019 |
| Q2 FY19Jul–Sep 2018 | 61.35 | — | (2.58) | — | (0.10) | 30 Oct 2018 |
| Q1 FY19Apr–Jun 2018 | 16.81 | — | (64.48) | — | (2.57) | 31 Jul 2018 |
45 filings on record for this company.